Gilmore O'Neill, M.B., M.M.Sc
2018
Compensation breakdown
| Non-Equity Incentive Plan | $213,354 |
|---|---|
| Option Awards | $4,768,050 |
| Salary | $310,962 |
| Stock Awards | $1,154,760 |
| Other | $2,050 |
| Total | $6,449,176 |
MMSc received $4.8M in option awards, accounting for 74% of the total pay in 2018.
MMSc also received $213.4K in non-equity incentive plan, $311K in salary, $1.2M in stock awards and $2.1K in other compensation.
Rankings
In 2018, Gilmore O'Neill, M.B., M.M.Sc's compensation ranked 1,410th out of 14,244 executives tracked by ExecPay. In other words, MMSc earned more than 90.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,410 out of 14,244 | 90th |
Division Manufacturing | 489 out of 5,765 | 92nd |
Major group Chemicals And Allied Products | 153 out of 2,128 | 93rd |
Industry group Drugs | 120 out of 1,817 | 93rd |
Industry Pharmaceutical Preparations | 88 out of 1,391 | 94th |
Pay ratio
| Gilmore O'Neill, M.B., M.M.Sc's Pay | $6,449,176 |
|---|---|
| Median Employee's Pay | $329,229 |
| Pay Ratio | 20to 1 |
In 2018, the annual total compensation of Gilmore O'Neill, M.B., M.M.Sc was $6,449,176.
The annual total compensation of the median employee at Sarepta Therapeutics was $329,229.
The ratio of Gilmore O'Neill, M.B., M.M.Sc's pay to the pay of median employee was therefore 20 to one.
MMSc's colleagues
We found four more compensation records of executives who worked with Gilmore O'Neill, M.B., M.M.Sc at Sarepta Therapeutics in 2018.